Skip to main content

Advertisement

ADVERTISEMENT

News

News
02/03/2020
Merit Medical Systems, Inc. announces that both its EmboCube (syringe-loaded embolization gelatin foam) and Torpedo (uniform, pre-shaped gelatin foam loaded into a cartridge with optional blunt stylet) devices are now FDA indicated for the...
Merit Medical Systems, Inc. announces that both its EmboCube (syringe-loaded embolization gelatin foam) and Torpedo (uniform, pre-shaped gelatin foam loaded into a cartridge with optional blunt stylet) devices are now FDA indicated for the...
Merit Medical Systems,...
02/03/2020
Vascular Disease Management
News
01/30/2020
Medtronic plc today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D).
Medtronic plc today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D).
Medtronic plc today announced it...
01/30/2020
Vascular Disease Management

Advertisement

News
01/28/2020
New Larger Implant Enables Focal Dissection Repair Across a Wider Range of Vessel Sizes<
New Larger Implant Enables Focal Dissection Repair Across a Wider Range of Vessel Sizes<
New Larger Implant Enables Focal...
01/28/2020
Vascular Disease Management

Advertisement

News
01/28/2020
Mortality rates similar to standard of care through four years with excellent rate of follow-up compliance Philips Stellarex is the only low-dose Drug-Coated Balloon (DCB) to demonstrate sustained treatment effect and high safety pr
Mortality rates similar to standard of care through four years with excellent rate of follow-up compliance Philips Stellarex is the only low-dose Drug-Coated Balloon (DCB) to demonstrate sustained treatment effect and high safety pr
Mortality rates similar to...
01/28/2020
Vascular Disease Management
News
01/28/2020
January 29, 2020, Miramar, FL – NAGLREITER™ (www.nmddo.com) is a MedTech “Elevator / Incubator” aimed at Innovating MedTech innovation.  The NAGLREITER™ model accelerates the time to market for startups as well as large industry advanced...
January 29, 2020, Miramar, FL – NAGLREITER™ (www.nmddo.com) is a MedTech “Elevator / Incubator” aimed at Innovating MedTech innovation.  The NAGLREITER™ model accelerates the time to market for startups as well as large industry advanced...
January 29, 2020, Miramar, FL...
01/28/2020
Vascular Disease Management
News
01/27/2020
With mortality rates similar to standard of care through four years with excellent rate of follow-up compliance, Philips Stellarex is the only low-dose drug-coated balloon (DCB) to demonstrate sustained treatment effect and high safety...
With mortality rates similar to standard of care through four years with excellent rate of follow-up compliance, Philips Stellarex is the only low-dose drug-coated balloon (DCB) to demonstrate sustained treatment effect and high safety...
With mortality rates similar to...
01/27/2020
Vascular Disease Management

Advertisement

News
01/18/2020
TORRANCE, Calif., Jan.
TORRANCE, Calif., Jan.
TORRANCE, Calif., Jan.
01/18/2020
Vascular Disease Management
News
01/17/2020
The meta-analysis published by Dr. Konstantinos Katsanos, et al in the Journal of Vascular and Interventional Radiology on January 14 focused on amputation-free survival (defined as freedom from all-cause mortality and major amputation) and...
The meta-analysis published by Dr. Konstantinos Katsanos, et al in the Journal of Vascular and Interventional Radiology on January 14 focused on amputation-free survival (defined as freedom from all-cause mortality and major amputation) and...
The meta-analysis published by...
01/17/2020
Vascular Disease Management

Advertisement